Home
/ ViewRay
/ Competitors

ViewRay Competitors and Similar CompaniesClear all

ViewRay's competitors and similar companies include Varian Medical Systems, Elekta, Accuray and Amethyst Radiotherapy.

	ViewRay ViewRay is a company that designs, manufactures, and markets MRIdian, an MRI-guided radiation therapy system.	Varian Medical Systems Varian Medical Systems is a manufacturer of medical devices and software for treating cancer and other medical conditions.	Elekta Elekta is a medical device company that manufactures radiotherapy solutions for cancer care and brain disorders.	Accuray Accuray is a radiation therapy company that develops, manufactures, sells, and supports radiation treatment solutions.	Amethyst Radiotherapy Amethyst Radiotherapy is a cancer treatment institution operating a network of radiotherapy centers.
Founding Date	Founding Date 2004	Founding Date 1948	Founding Date 1972	Founding Date 1990	Founding Date N/A
Type	Type Public	Type Subsidiary	Type Public	Type Public	Type Private
Tags	Tags Technology medtech oncology therapy	Tags Manufacturing & Industrial medical devices medical imaging medtech oncology	Tags Technology medtech oncology therapy	Tags Manufacturing & Industrial medical devices medtech oncology therapy	Tags Healthcare medtech oncology therapy
Locations	Locations Oakwood Village, US HQ Mountain View, US	Locations Palo Alto, US HQ Alger, DZ Belrose, AU Brunn Am Gebirge, AT Dilbeek, BE San Paulo, BR Winnipeg, CA see more	Locations Stockholm, SE HQ North Sydney, AU Innsbruck, AT Zaventem, BE São Paulo, BR Montréal, CA Beijing, CN see more	Locations Madison, US HQ Chengdu, CN Kowloon, HK Tokyo, JP Morges, CH Santa Clara, US Sunnyvale, US	Locations Amsterdam, NL HQ
Employees	Employees 29510% increase	Employees 9,908	Employees 4,541	Employees 9874% decrease	Employees 235% increase
Valuation ($)	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) 2.4 b	Valuation ($) 186.5 m	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) $102.2m (FY, 2022)	Revenue (est.) €4.1b (FY, 2025)	Revenue (est.) kr18b (FY, 2025)	Revenue (est.) $458.5m (FY, 2025)	Revenue (est.) N/A
Cost of goods	Cost of goods $92.2m (FY, 2022)	Cost of goods N/A	Cost of goods kr11.1b (FY, 2025)	Cost of goods $311.5m (FY, 2025)	Cost of goods N/A
Gross profit	Gross profit $10m (FY, 2022)	Gross profit N/A	Gross profit kr6.9b (FY, 2025)	Gross profit $147m (FY, 2025)	Gross profit N/A
Net income	Net income ($107.3m) (FY, 2022)	Net income N/A	Net income kr240m (FY, 2025)	Net income ($1.6m) (FY, 2025)	Net income N/A
Operating ⚠
Backlog	Backlog $241.3m (FY, 2020)	Backlog N/A	Backlog N/A	Backlog $495.6m (FY, 2019)	Backlog N/A
Facility Space Leased, sq. ft.	Facility Space Leased, sq. ft. 89.7 k (FY, 2020)	Facility Space Leased, sq. ft. N/A	Facility Space Leased, sq. ft. N/A	Facility Space Leased, sq. ft. 384 k (FY, 2019)	Facility Space Leased, sq. ft. N/A
Funding
Total funding raised	Total funding raised $ 84.8m	Total funding raised $ 9.5m	Total funding raised N/A	Total funding raised N/A	Total funding raised N/A